Biomarkers of Homeopathy in Fibromyalgia
Fibromyalgia
About this trial
This is an interventional treatment trial for Fibromyalgia focused on measuring fibromyalgia, homeopathy, EEG, EKG, chronic pain
Eligibility Criteria
Inclusion criteria: ACR diagnosis of fibromyalgia; Willing to take daily active or placebo liquid remedy under double blind conditions for 6 months, involving daily succussion and dilution of source liquid from a stock bottle; Willingness/ability to comply with dietary and lifestyle restrictions, i.e., no coffee in any form, no comphor or menthol-containing products; no electric blankets, no strong aromatics, no routine vaccinations, no concomitant use of acupuncture, chiropractic, polarity therapy, psychic healing, or magnet therapy; No dental drilling, MRI scans unless emergent; Withhold food or drink 30 mins before/after therapy; Stable conventional care for 2 months prior to entry; Willing to undergo 3 diagnostic physical exams, and to permit videotaping of interview sessions; Willing to fill out questionnaires Exclusion criteria: Steroid-dependent medical conditions; Chronic benzodiazepine or anticonvulsant use; Use of tricyclic antidepressants, antihypertensives, and other drugs that alter orthostasis; Pregnancy; History of seizure disorder or syncope; Life-threatening medical conditions; Current active asthma; History of anaphylactic shock; Insulin-dependent diabetes; Active suicidal ideation or psychosis.
Sites / Locations
- U of Arizona College of Medicine, Program in Integrative Medicine